Baidu
map

Hepatology:外显子组测序发现UBE3C可能是肝癌重要候选基因

2014-01-19 MedSci MedSci原创

来自复旦大学的研究人员采用外显子(exome)组测序技术,揭示出了一个叫做UBE3C的基因在肝细胞癌中具有重要的临床意义。相关研究论文已被在国际著名肝脏疾病杂志Hepatology(最新影响因子12.003)接受并在线发布。 复旦大学附属中山医院的周俭(Jian Zhou)教授和黄晓武(Xiao-Wu Huang)博士是这篇论文的共同通讯作者。前者主要擅长各种肝肿瘤疑难杂症的诊断、治疗与肝脏移植

来自复旦大学的研究人员采用外显子(exome)组测序技术,揭示出了一个叫做UBE3C的基因在肝细胞癌中具有重要的临床意义。相关研究论文已被在国际著名肝脏疾病杂志Hepatology(最新影响因子12.003)接受并在线发布。

复旦大学附属中山医院的周俭(Jian Zhou)教授和黄晓武(Xiao-Wu Huang)博士是这篇论文的共同通讯作者。前者主要擅长各种肝肿瘤疑难杂症的诊断、治疗与肝脏移植。后者则擅长原发性肝癌、转移性肝癌以及肝血管瘤、结节性增生、肝囊肿等肝脏良恶性肿瘤的外科切除,及肝脏移植。

原发性肝癌是人类常见的恶性肿瘤之一,全世界每年新增50万~100 万病例。5年死亡率超过90%。我国是肝癌的高发地区 近年发病率呈缓慢上升趋势,病死率也随之上升,占癌症死亡率的第三位。研究确认, 原发性肝癌与乙型肝炎病毒及丙型肝炎病毒感染密切相关。肝细胞癌是原发性肝癌的一种主要类型,也是恶性程度最高的肿瘤之一。50%-80%以上的肝细胞癌因持续的乙型肝炎病毒感染所致,大约25%由于持续的丙型肝炎病毒感染。

病毒诱导肝癌形成涉及一连串的组织学演化过程,逐步获得一些遗传改变是肝细胞发生恶性转变的必要条件。尽管近年来的研究已经确定了一些与肝细胞癌发病机制相关的遗传改变,对于促成这一过程的特异基因仍知之甚少。

为了深入地了解从乙肝病毒感 染到癌前病变的不典型增生结节(dysplastic nodule,DN)、至肝癌形成这一肿瘤进化过程中相关的遗传改变,研究人员首先对4个DNA样本进行了外显子组测序:其中包括1个不典型增生结节样 本,两个肝癌样本,和来自一名肝癌患者的对照外周血样本。研究人员在两个肿瘤样本中观察到UBE3C基因发生了突变。

随后,他们对另外105名肝癌患者中对UBE3C基因进行了重测序验证,确定其中有17人(16.0%)存在UBE3C基因突变。利用一些实验,他们证实UBE3C通过调控肝癌细胞的上皮间质转化促进了肝癌的进程。针对323名临床肝癌患者进行组织微阵列研究的结果表明,原发性肝癌组织中UBE3C 过表达与肝癌患者手术后生存率降低以及早期肿瘤复发密切相关。

这些研究结果表明,UBE3C有可能是与肝癌形成和进展相关一个重要的候选癌基因,由此为肝癌治疗提供了一个新的潜在治疗靶点。

另外,据韩国研究表明这个基因与哮喘有密切关系。

原始出处:

Jiang JH, Liu YF, Ke AW, Gu FM, Yu Y, Dai Z, Gao Q, Shi GM, Liao BY, Xie YH, Fan J, Huang XW, Zhou J.Clinical significance of the ubiquitin ligase E3C in hepatocellular carcinoma revealed by exome sequencing.Hepatology. 2014 Jan 15. doi: 10.1002/hep.27012.

相关文献:

Pasaje CF, Kim JH, Park BL, Park JS, Uh ST, Kim MK, Park CS, Shin HD.UBE3C genetic variations as potent markers of nasal polyps in Korean asthma patients.J Hum Genet. 2011 Nov;56(11):797-800.

Lee JS, Kim JH, Bae JS, Kim JY, Park TJ, Pasaje CF, Park BL, Cheong HS, Park JS, Uh ST, Kim MK, Choi IS, Cho SH, Choi BW, Park CS, Shin HD.Association analysis of UBE3C polymorphisms in Korean aspirin-intolerant asthmatic patients.Ann Allergy Asthma Immunol. 2010 Oct;105(4):307-312.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1689709, encodeId=28291689e09a8, content=<a href='/topic/show?id=4bf4428668c' target=_blank style='color:#2F92EE;'>#外显子组测序#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42866, encryptionId=4bf4428668c, topicName=外显子组测序)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c628851013, createdName=dlwang_26703136, createdTime=Sun Jul 20 11:17:00 CST 2014, time=2014-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796539, encodeId=3d421e9653971, content=<a href='/topic/show?id=5d111806299' target=_blank style='color:#2F92EE;'>#UBE3C#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18062, encryptionId=5d111806299, topicName=UBE3C)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XhttJCp4Aq9gKA5n4v9elclQlVQTDenMiaEiadlI5D3gtmfSiaicoIY4ZsuibrQKLibDdxBKVY8oS6B2FicqJlT93clow/132, createdBy=03202500144, createdName=ms7258648636991762, createdTime=Fri Dec 12 19:17:00 CST 2014, time=2014-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1739856, encodeId=11291e39856ec, content=<a href='/topic/show?id=be3f2e4673d' target=_blank style='color:#2F92EE;'>#候选基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27467, encryptionId=be3f2e4673d, topicName=候选基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf3934589081, createdName=12498a1cm78暂无昵称, createdTime=Thu May 29 04:17:00 CST 2014, time=2014-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684239, encodeId=3b1c168423941, content=<a href='/topic/show?id=a2a842865e7' target=_blank style='color:#2F92EE;'>#外显子组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42865, encryptionId=a2a842865e7, topicName=外显子组)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5dc28064977, createdName=achengzhao, createdTime=Mon Dec 22 22:17:00 CST 2014, time=2014-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426576, encodeId=eb9514265e6e1, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Tue Jan 21 12:17:00 CST 2014, time=2014-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619021, encodeId=71751619021ae, content=<a href='/topic/show?id=492a42862bd' target=_blank style='color:#2F92EE;'>#外显子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42862, encryptionId=492a42862bd, topicName=外显子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Jan 21 12:17:00 CST 2014, time=2014-01-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1689709, encodeId=28291689e09a8, content=<a href='/topic/show?id=4bf4428668c' target=_blank style='color:#2F92EE;'>#外显子组测序#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42866, encryptionId=4bf4428668c, topicName=外显子组测序)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c628851013, createdName=dlwang_26703136, createdTime=Sun Jul 20 11:17:00 CST 2014, time=2014-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796539, encodeId=3d421e9653971, content=<a href='/topic/show?id=5d111806299' target=_blank style='color:#2F92EE;'>#UBE3C#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18062, encryptionId=5d111806299, topicName=UBE3C)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XhttJCp4Aq9gKA5n4v9elclQlVQTDenMiaEiadlI5D3gtmfSiaicoIY4ZsuibrQKLibDdxBKVY8oS6B2FicqJlT93clow/132, createdBy=03202500144, createdName=ms7258648636991762, createdTime=Fri Dec 12 19:17:00 CST 2014, time=2014-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1739856, encodeId=11291e39856ec, content=<a href='/topic/show?id=be3f2e4673d' target=_blank style='color:#2F92EE;'>#候选基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27467, encryptionId=be3f2e4673d, topicName=候选基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf3934589081, createdName=12498a1cm78暂无昵称, createdTime=Thu May 29 04:17:00 CST 2014, time=2014-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684239, encodeId=3b1c168423941, content=<a href='/topic/show?id=a2a842865e7' target=_blank style='color:#2F92EE;'>#外显子组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42865, encryptionId=a2a842865e7, topicName=外显子组)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5dc28064977, createdName=achengzhao, createdTime=Mon Dec 22 22:17:00 CST 2014, time=2014-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426576, encodeId=eb9514265e6e1, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Tue Jan 21 12:17:00 CST 2014, time=2014-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619021, encodeId=71751619021ae, content=<a href='/topic/show?id=492a42862bd' target=_blank style='color:#2F92EE;'>#外显子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42862, encryptionId=492a42862bd, topicName=外显子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Jan 21 12:17:00 CST 2014, time=2014-01-21, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1689709, encodeId=28291689e09a8, content=<a href='/topic/show?id=4bf4428668c' target=_blank style='color:#2F92EE;'>#外显子组测序#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42866, encryptionId=4bf4428668c, topicName=外显子组测序)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c628851013, createdName=dlwang_26703136, createdTime=Sun Jul 20 11:17:00 CST 2014, time=2014-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796539, encodeId=3d421e9653971, content=<a href='/topic/show?id=5d111806299' target=_blank style='color:#2F92EE;'>#UBE3C#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18062, encryptionId=5d111806299, topicName=UBE3C)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XhttJCp4Aq9gKA5n4v9elclQlVQTDenMiaEiadlI5D3gtmfSiaicoIY4ZsuibrQKLibDdxBKVY8oS6B2FicqJlT93clow/132, createdBy=03202500144, createdName=ms7258648636991762, createdTime=Fri Dec 12 19:17:00 CST 2014, time=2014-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1739856, encodeId=11291e39856ec, content=<a href='/topic/show?id=be3f2e4673d' target=_blank style='color:#2F92EE;'>#候选基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27467, encryptionId=be3f2e4673d, topicName=候选基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf3934589081, createdName=12498a1cm78暂无昵称, createdTime=Thu May 29 04:17:00 CST 2014, time=2014-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684239, encodeId=3b1c168423941, content=<a href='/topic/show?id=a2a842865e7' target=_blank style='color:#2F92EE;'>#外显子组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42865, encryptionId=a2a842865e7, topicName=外显子组)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5dc28064977, createdName=achengzhao, createdTime=Mon Dec 22 22:17:00 CST 2014, time=2014-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426576, encodeId=eb9514265e6e1, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Tue Jan 21 12:17:00 CST 2014, time=2014-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619021, encodeId=71751619021ae, content=<a href='/topic/show?id=492a42862bd' target=_blank style='color:#2F92EE;'>#外显子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42862, encryptionId=492a42862bd, topicName=外显子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Jan 21 12:17:00 CST 2014, time=2014-01-21, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1689709, encodeId=28291689e09a8, content=<a href='/topic/show?id=4bf4428668c' target=_blank style='color:#2F92EE;'>#外显子组测序#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42866, encryptionId=4bf4428668c, topicName=外显子组测序)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c628851013, createdName=dlwang_26703136, createdTime=Sun Jul 20 11:17:00 CST 2014, time=2014-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796539, encodeId=3d421e9653971, content=<a href='/topic/show?id=5d111806299' target=_blank style='color:#2F92EE;'>#UBE3C#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18062, encryptionId=5d111806299, topicName=UBE3C)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XhttJCp4Aq9gKA5n4v9elclQlVQTDenMiaEiadlI5D3gtmfSiaicoIY4ZsuibrQKLibDdxBKVY8oS6B2FicqJlT93clow/132, createdBy=03202500144, createdName=ms7258648636991762, createdTime=Fri Dec 12 19:17:00 CST 2014, time=2014-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1739856, encodeId=11291e39856ec, content=<a href='/topic/show?id=be3f2e4673d' target=_blank style='color:#2F92EE;'>#候选基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27467, encryptionId=be3f2e4673d, topicName=候选基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf3934589081, createdName=12498a1cm78暂无昵称, createdTime=Thu May 29 04:17:00 CST 2014, time=2014-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684239, encodeId=3b1c168423941, content=<a href='/topic/show?id=a2a842865e7' target=_blank style='color:#2F92EE;'>#外显子组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42865, encryptionId=a2a842865e7, topicName=外显子组)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5dc28064977, createdName=achengzhao, createdTime=Mon Dec 22 22:17:00 CST 2014, time=2014-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426576, encodeId=eb9514265e6e1, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Tue Jan 21 12:17:00 CST 2014, time=2014-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619021, encodeId=71751619021ae, content=<a href='/topic/show?id=492a42862bd' target=_blank style='color:#2F92EE;'>#外显子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42862, encryptionId=492a42862bd, topicName=外显子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Jan 21 12:17:00 CST 2014, time=2014-01-21, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1689709, encodeId=28291689e09a8, content=<a href='/topic/show?id=4bf4428668c' target=_blank style='color:#2F92EE;'>#外显子组测序#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42866, encryptionId=4bf4428668c, topicName=外显子组测序)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c628851013, createdName=dlwang_26703136, createdTime=Sun Jul 20 11:17:00 CST 2014, time=2014-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796539, encodeId=3d421e9653971, content=<a href='/topic/show?id=5d111806299' target=_blank style='color:#2F92EE;'>#UBE3C#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18062, encryptionId=5d111806299, topicName=UBE3C)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XhttJCp4Aq9gKA5n4v9elclQlVQTDenMiaEiadlI5D3gtmfSiaicoIY4ZsuibrQKLibDdxBKVY8oS6B2FicqJlT93clow/132, createdBy=03202500144, createdName=ms7258648636991762, createdTime=Fri Dec 12 19:17:00 CST 2014, time=2014-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1739856, encodeId=11291e39856ec, content=<a href='/topic/show?id=be3f2e4673d' target=_blank style='color:#2F92EE;'>#候选基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27467, encryptionId=be3f2e4673d, topicName=候选基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf3934589081, createdName=12498a1cm78暂无昵称, createdTime=Thu May 29 04:17:00 CST 2014, time=2014-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684239, encodeId=3b1c168423941, content=<a href='/topic/show?id=a2a842865e7' target=_blank style='color:#2F92EE;'>#外显子组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42865, encryptionId=a2a842865e7, topicName=外显子组)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5dc28064977, createdName=achengzhao, createdTime=Mon Dec 22 22:17:00 CST 2014, time=2014-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426576, encodeId=eb9514265e6e1, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Tue Jan 21 12:17:00 CST 2014, time=2014-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619021, encodeId=71751619021ae, content=<a href='/topic/show?id=492a42862bd' target=_blank style='color:#2F92EE;'>#外显子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42862, encryptionId=492a42862bd, topicName=外显子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Jan 21 12:17:00 CST 2014, time=2014-01-21, status=1, ipAttribution=)]
    2014-01-21 gwc384
  6. [GetPortalCommentsPageByObjectIdResponse(id=1689709, encodeId=28291689e09a8, content=<a href='/topic/show?id=4bf4428668c' target=_blank style='color:#2F92EE;'>#外显子组测序#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42866, encryptionId=4bf4428668c, topicName=外显子组测序)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c628851013, createdName=dlwang_26703136, createdTime=Sun Jul 20 11:17:00 CST 2014, time=2014-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796539, encodeId=3d421e9653971, content=<a href='/topic/show?id=5d111806299' target=_blank style='color:#2F92EE;'>#UBE3C#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18062, encryptionId=5d111806299, topicName=UBE3C)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XhttJCp4Aq9gKA5n4v9elclQlVQTDenMiaEiadlI5D3gtmfSiaicoIY4ZsuibrQKLibDdxBKVY8oS6B2FicqJlT93clow/132, createdBy=03202500144, createdName=ms7258648636991762, createdTime=Fri Dec 12 19:17:00 CST 2014, time=2014-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1739856, encodeId=11291e39856ec, content=<a href='/topic/show?id=be3f2e4673d' target=_blank style='color:#2F92EE;'>#候选基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27467, encryptionId=be3f2e4673d, topicName=候选基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf3934589081, createdName=12498a1cm78暂无昵称, createdTime=Thu May 29 04:17:00 CST 2014, time=2014-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684239, encodeId=3b1c168423941, content=<a href='/topic/show?id=a2a842865e7' target=_blank style='color:#2F92EE;'>#外显子组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42865, encryptionId=a2a842865e7, topicName=外显子组)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5dc28064977, createdName=achengzhao, createdTime=Mon Dec 22 22:17:00 CST 2014, time=2014-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426576, encodeId=eb9514265e6e1, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Tue Jan 21 12:17:00 CST 2014, time=2014-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619021, encodeId=71751619021ae, content=<a href='/topic/show?id=492a42862bd' target=_blank style='color:#2F92EE;'>#外显子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42862, encryptionId=492a42862bd, topicName=外显子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Jan 21 12:17:00 CST 2014, time=2014-01-21, status=1, ipAttribution=)]

相关资讯

JGH:肝细胞癌——手术切除与TACE孰优?

韩国成钧馆大学医学院的Moon Seok Choi医生和他的同事们对手术切除肝巨大肿瘤和肝动脉化疗栓塞的远期疗效进行了对比,并对与生存期有关的预后因素进行了评估。自2000年至2009年,有84位患者进行了手术切除,267位患者行肝动脉化疗栓塞。研究者们收集了患者的年龄、性别、肝病病因、是否存在肝硬化和肝功能分级,以及肿瘤大小、数目、范围和血管侵蚀情况的数据信息。主要评价项目是总生存期。其他评

Gut:HBV血清标志物的自发清除是肝癌风险降低的预测因素

研究要点:1.在长期随访测量一系列HBV血清标志物的研究中,HBV DNA的血清清除对于显著降低肝癌风险是至关重要的。2.HBsAg血清清除对于确保HBV完全免疫清除是必要的。3.HBeAg的血清清除并非如之前研究的一样重要,因为患者血清清除HBeAg后仍有血清HBV DNA高水平。先前研究中观察到肝癌风险降低与HBeAg的血清清除存在相关可能是由于它与随后血清HBV-DNA的清除相关联,而不

Ann Surg Oncol:AFP分层有利于预测乙肝相关肝癌预后

研究要点 1.手术前的AFP检测是乙肝相关性肝癌切除术预后的预测指标。 2.将AFP分层和纤维化分层相结合就可以建立预测HCC预后的模型。 3.在现行的诊断标准下,即使AFP处于正常范围,不同的AFP也会影响HBV相关的肝癌的疾病进展和预后。 甲胎蛋白(AFP)水平与乙肝相关性肝细胞肝癌有关。虽然血浆AFP是影响病人生存率的指标之一,但最理想的临界值是多少还未知。来自美国的研究人员

Hepatology:肝癌形成分子调控机制获发现

来自第二军医大学的研究人员在新研究中证实,miR-370/Lin28A /NF-κB调控环路失常促进了肝癌形成。这一研究发现在线发表在国际著名肝脏疾病杂志Hepatology(最新影响因子12.003)上。

第二军医大学长征医院消化内科的谢渭芬(Wei-Fen Xie)教授是这篇论文的通讯作者。主要研究方向为慢性肝病的诊治。对脂肪肝、肝硬化等慢性肝病、胆道和胰腺疾病、胃肠疾病等消化道疾病的诊治积累了较丰富的经验。擅长胃镜、十二指肠镜、小肠镜等内镜诊断和治疗。2009年入选教育部“***奖励计划”特聘教授。先后发表SCI收录论著40余篇。

在世界范围内,原发性肝癌是第五大类常见的恶性肿瘤,其致死率在肿瘤相关疾病中排名第三,仅次于

Cancer Cell:曹雪涛课题组发现肝癌发生和干扰素疗效预判新靶标

2014年1月15日,国际肿瘤学研究顶尖杂志《癌细胞》(Cancer Cell,影响因子25分)以封面论文的形式发表了中国医学科学院院长、医学免疫学国家重点实验室主任曹雪涛院士课题组侯晋副教授、周烨和郑媛媛博士及其合作者的研究论文,报道了其发现维甲酸诱导基因-I(RIG-I)在肝癌预后判断、干扰素治疗疗效预判和肝癌发生尤其是男性高发中的作用和机制。该肝癌转化医学研究工作为肝癌预后判断和干扰素治疗疗

Cancer Cell:NCOA5基因缺陷可能导致肝细胞癌、葡萄糖耐受不良

来自密歇根州立大学和南方医科大学的研究人员发现,一种遗传缺陷可以触发男性形成最常见的一种肝癌类型和糖尿病。这项研究在线发表于12月9日的《癌细胞》(Cancer Cell)杂志上。 南方医科大学南方医院罗荣城(Rongcheng Luo)教授和密歇根州立大学医学院生理学副教授肖华(Hua Xiao,音译)是这篇论文的共同通讯作者。罗荣城教授长期从事临床非常肿瘤学医教研

Baidu
map
Baidu
map
Baidu
map